Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Common Share (Details)

v3.21.2
Net Income (Loss) Per Common Share (Details) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 30, 2021
Oct. 31, 2020
Oct. 30, 2021
Oct. 31, 2020
Numerator:        
Net loss $ (9,492,000) $ (4,748,000) $ (16,970,000) $ (10,522,000)
Earnings allocated to participating share awards 0 0 0 0
Net loss attributable to common shares - Basic and diluted $ (9,492,000) $ (4,748,000) $ (16,970,000) $ (10,522,000)
Denominator:        
Weighted average number of common shares outstanding - Basic (a) 21,503,340 12,177,990 18,710,658 10,000,383
Dilutive effect of stock options, non-vested shares and warrants (b) 0 0 0 0
Weighted average number of common shares outstanding - Diluted 21,503,340 12,177,990 18,710,658 10,000,383
Net loss per common share $ (0.44) $ (0.39) $ (0.91) $ (1.05)
Net loss per common share - assuming dilution $ (0.44) $ (0.39) $ (0.91) $ (1.05)
Incremental common shares includes in calculation of basic EPS attributable to the effect of fully-paid warrants 21,000   21,000  
Warrant exercise price per share $ 0.001   $ 0.001  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 658,000 992,000 796,000 476,000